ArticleBritish journal of pharmacology2014

The dual PPARα/γ agonist aleglitazar increases the number and function of endothelial progenitor cells: implications for vascular function and atherogenesis.

C M Werner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.